Comparing kushmanda ghrita with goghrita in the management of premenstrual syndrome

Comparative clinical study of kushmanda ghrita and goghrita in premenstrual syndrome - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099495

Enrollment

Registered

2025-12-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N943- Premenstrual tension syndrome

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling diagnostic criteria Women in age group of 16 to 30 years Unmarried women Women having regular (3 to 5 days/28days)menstrual cycle Mild to severe symptomatic cases

Exclusion criteria

Exclusion criteria: Patient diagnosed with psychiatric disorder Patient diagnosed with any pelvic pathology Patient diagnosed with any systemic disorders By using PMDD scale patients of premenstrual dysphoric disorder will be excluded Patient with very severe symptoms

Design outcomes

Primary

Measure	Time frame
The effect of treatment is assessed on the basis of 1. Subjective criteria symptoms appear during 15th to 28th day of menstrual cycles 2. Objective criteria symptomatic analysis based on actual and percentage PMS scale scoringTimepoint: Treatment duration is two consecutive cycle and assessment will be done on 15th 21st and 28th day of menstrual cycle and follow up is on 3rd consecutive cycle on 15th 21st 28th day of menstrual cycle after treatment	—

Measure

Time frame

The effect of treatment is assessed on the basis of 1. Subjective criteria symptoms appear during 15th to 28th day of menstrual cycles 2. Objective criteria symptomatic analysis based on actual and percentage PMS scale scoringTimepoint: Treatment duration is two consecutive cycle and assessment will be done on 15th 21st and 28th day of menstrual cycle and follow up is on 3rd consecutive cycle on 15th 21st 28th day of menstrual cycle after treatment

—

Secondary

Measure	Time frame
Observe the changes in menstrual symptoms and physiological ,psychological, behavioural symptoms in PMS. To evaluate whether kushmanda ghrita is better effective than goghrita or vice versaTimepoint: Follow up will be done on 3rd consecutive cycle on 15th 21st 28th day of menstrual cycle after treatment	—

Countries

India

Contacts

Public ContactDr Shete Susmita Chandrakant

Alvas ayurveda medical college and hospital

shrusharma90@gmail.com9986210758

Outcome results